AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Mahon, FX
Citation: Fx. Mahon, Chronic myelogenous leukemic and tyrosine kinase inhibitors., REV MED IN, 22(9), 2001, pp. 894-899

Authors: Barthe, C Cony-Makhoul, P Melo, JV Reiffers, J Mahon, FX
Citation: C. Barthe et al., Roots of clinical resistance to STI-571 cancer therapy, SCIENCE, 293(5538), 2001, pp. NIL_1-NIL_1

Authors: Deininger, MWN Vieira, SAD Parada, Y Banerji, L Lam, EWF Peters, G Mahon, FX Kohler, T Goldman, JM Melo, JV
Citation: Mwn. Deininger et al., Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts, CANCER RES, 61(21), 2001, pp. 8005-8013

Authors: Etienne, G Mahon, FX
Citation: G. Etienne et Fx. Mahon, Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia, B CANCER, 88(7), 2001, pp. 651-658

Authors: Tipping, AJ Mahon, FX Lagarde, V Goldman, JM Melo, JV
Citation: Aj. Tipping et al., Restoration of sensitivity to STI571 in ST1571-resistant chronic myeloid leukemia cells, BLOOD, 98(13), 2001, pp. 3864-3867

Authors: Bonifazi, F de Vivo, A Rosti, G Guilhot, F Guilhot, J Trabacchi, E Hehlmann, R Hochhaus, A Shepherd, PCA Steegmann, JL Kluin-Nelemans, HC Thaler, J Simonsson, B Louwagie, A Reiffers, J Mahon, FX Montefusco, E Alimena, G Hasford, J Richards, S Saglio, G Testoni, N Martinelli, G Tura, S Baccarani, M
Citation: F. Bonifazi et al., Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders, BLOOD, 98(10), 2001, pp. 3074-3081

Authors: Barthe, C Mahon, FX Gharbi, MJ Faberes, C Bilhou-Nabera, C Hochhaus, A Reiffers, J Marit, G
Citation: C. Barthe et al., Expression of interferon-alpha (IFN-alpha) receptor 2c at diagnosis is associated with cytogenetic response in IFN-alpha-treated chronic myeloid leukemia, BLOOD, 97(11), 2001, pp. 3568-3573

Authors: Salesse, S Lagarde, V Ged, C De Verneuil, H Reiffers, J Mahon, FX
Citation: S. Salesse et al., Retroviral coexpression of IFN-alpha and IFN-gamma genes and inhibitory effects in chronic myeloid leukemia cells, J INTERF CY, 20(6), 2000, pp. 577-587

Authors: Pigneux, A Mahon, FX Jazwiec, B Pigeonnier, V Ripoche, J Reiffers, J
Citation: A. Pigneux et al., Effect of antisense oligonucleotides on CD34+cells from chronic myeloid leukemia, LEUK LYMPH, 36(5-6), 2000, pp. 569-578

Authors: Marit, G Cao, YX Froussard, P Ripoche, J Dupouy, M Elandaloussi, A Lacombe, F Mahon, FX Keller, H Pla, M Reiffers, J Theze, J
Citation: G. Marit et al., Increased liposome-mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayers, EUR J HAEMA, 64(1), 2000, pp. 22-31

Authors: Solanilla, A Grosset, C Lemercier, C Dupouy, M Mahon, FX Schweitzer, K Reiffers, J Weksler, B Ripoche, J
Citation: A. Solanilla et al., Expression of Flt3-ligand by the endothelial cell, LEUKEMIA, 14(1), 2000, pp. 153-162

Authors: Solanilla, A El Andaloussi, A Grosset, C Duchez, P Mossalayi, MD Mahon, FX Reiffers, J Marit, G Ripoche, J
Citation: A. Solanilla et al., Differential effect of interferon alpha on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co-culture context: role of the flt3 ligand, BR J HAEM, 109(2), 2000, pp. 382-387

Authors: Sainty, D Liso, V Cantu-Rajnoldi, A Head, D Mozziconacci, MJ Arnoulet, C Benattar, L Fenu, S Mancini, M Duchayne, E Mahon, FX Gutierrez, N Birg, F Biondi, A Grimwade, D Lafage-Pochitaloff, M Hagemeijer, A Flandrin, G
Citation: D. Sainty et al., A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements, BLOOD, 96(4), 2000, pp. 1287-1296

Authors: Mahon, FX Deininger, MWN Schultheis, B Chabrol, J Reiffers, J Goldman, JM Melo, JV
Citation: Fx. Mahon et al., Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance, BLOOD, 96(3), 2000, pp. 1070-1079

Authors: Pigneux, A Mahon, FX Reiffers, J
Citation: A. Pigneux et al., Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts, BAIL CLIN H, 12(1-2), 1999, pp. 193-198

Authors: Pigneux, A Faberes, C Boiron, JM Mahon, FX Cony-Makhoul, P Agape, P Lounici, A Bernard, P Bilhou-Nabera, C Bouzgarrou, R Marit, G Reiffers, J
Citation: A. Pigneux et al., Autologous stem cell transplantation in chronic myeloid leukemia: a singlecenter experience, BONE MAR TR, 24(3), 1999, pp. 265-270

Authors: Labouyrie, E Dubus, P Groppi, A Mahon, FX Ferrer, J Parrens, M Reiffers, J de Mascarel, A Merlio, JP
Citation: E. Labouyrie et al., Expression of neurotrophins and their receptors in human bone marrow, AM J PATH, 154(2), 1999, pp. 405-415

Authors: Mahon, FX Pigeonnier-Lagarde, V Chahine, H Maguer-Satta, V Ripoche, J Reiffers, J
Citation: Fx. Mahon et al., Ex vivo cytokine expansion of peripheral blood Ph-negative cells in chronic myeloid leukaemia, LEUK LYMPH, 32(1-2), 1998, pp. 151-157

Authors: Salesse, S Moreau-Gaudry, F Pigeonnier-Lagarde, V Mazurier, F Chahine, H Ged, C de Verneuil, H Reiffers, J Mahon, FX
Citation: S. Salesse et al., Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cells, CANC GENE T, 5(6), 1998, pp. 390-400
Risultati: 1-19 |